Literature DB >> 23408086

Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case.

Kishu Fujita1, Mitsumasa Hata, Akira Sezai, Kazutomo Minami.   

Abstract

A 59-year-old female underwent surgery for a primary malignant pericardial mesothelioma. She presented with progressive dyspnea, and several imaging studies demonstrated a 65 × 22 mm tumor in the aortopulmonary window, accompanied by massive pericardial effusion. The tumor was successfully excised with clean surgical margins under cardiopulmonary bypass, followed by patch reconstruction of the pulmonary artery, and was diagnosed as an epithelioid type of malignant pericardial mesothelioma. The patient tolerated the operation and subsequent adjuvant chemotherapy without any complications. She remained alive and asymptomatic for almost 3 years after surgery, despite the fact that the median survival of this disease is 6-10 months. This patient is the second longest postoperative survivor of this extremely rare, aggressive neoplasm.

Entities:  

Mesh:

Year:  2013        PMID: 23408086     DOI: 10.1007/s00595-013-0511-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Primary pericardial mesothelioma presenting as constrictive pericarditis.

Authors:  G Oreopoulos; L Mickleborough; L Daniel; M De Sa; N Merchant; J Butany
Journal:  Can J Cardiol       Date:  1999-12       Impact factor: 5.223

2.  Primary mesothelioma of the pericardium. Successful surgical removal.

Authors:  B N Dooley; C Beckmann; R H Hood
Journal:  J Thorac Cardiovasc Surg       Date:  1968-05       Impact factor: 5.209

3.  Mesothelioma of the pericardium.

Authors:  I Juvara; C Dragomirescu; O Tomescu; D Velican
Journal:  J Cardiovasc Surg (Torino)       Date:  1970 May-Jun       Impact factor: 1.888

Review 4.  Primary malignant pericardial mesothelioma: a case report and review.

Authors:  T K Kaul; B L Fields; D R Kahn
Journal:  J Cardiovasc Surg (Torino)       Date:  1994-06       Impact factor: 1.888

5.  Pericardial mesothelioma: the diagnostic dilemma of misleading images.

Authors:  D W Quinn; F Qureshi; I M Mitchell
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

Review 6.  Malignant pericardial diseases: diagnosis and treatment.

Authors:  J Kralstein; W Frishman
Journal:  Am Heart J       Date:  1987-03       Impact factor: 4.749

Review 7.  Primary malignant mesothelioma of the pericardium. Case report and literature review.

Authors:  R Thomason; W Schlegel; M Lucca; S Cummings; S Lee
Journal:  Tex Heart Inst J       Date:  1994

8.  Primary malignant pericardial mesothelioma - a rare cause of pericardial effusion and consecutive constrictive pericarditis: a case report.

Authors:  Thomas Butz; Lothar Faber; Christoph Langer; Jan Körfer; Oliver Lindner; Andrea Tannapfel; Klaus-Michael Müller; Axel Meissner; Gunnar Plehn; Hans-Joachim Trappe; Dieter Horstkotte; Cornelia Piper
Journal:  J Med Case Rep       Date:  2009-09-17

Review 9.  Primary pericardial mesothelioma.

Authors:  Neyyir Tuncay Eren; A Ruchan Akar
Journal:  Curr Treat Options Oncol       Date:  2002-10

10.  Primary Pericardial Mesothelioma: Report of a Patient and Literature Review.

Authors:  Ase Nilsson; Torgny Rasmuson
Journal:  Case Rep Oncol       Date:  2009-07-29
  10 in total
  6 in total

1.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

2.  Positive response of a primary malignant pericardial mesothelioma to pemetrexed plus cisplatin followed by pemetrexed maintenance chemotherapy: A case report.

Authors:  Sang Mi Chung; Seong Ji Choi; Min Jung Kim; Jung Yoon Choi; Hong Jun Kim; Suk-Young Lee; Eun Joo Kang
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

Review 3.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

4.  The Antemortem Diagnosis of Primary Malignant Pericardial Mesothelioma: A Multidisciplinary Evaluation.

Authors:  Kohei Shikano; Satoshi Hirano; Takuma Hiroishi; Noriko Hayama; Tetsuo Fujita; Hiroyuki Amano; Makoto Nakamura; Sukeyuki Nakamura; Hiroshi Tabeta; Shuji Ichinose; Osamu Uchida; Shinichiro Shimizu
Journal:  Intern Med       Date:  2018-04-27       Impact factor: 1.271

5.  Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost.

Authors:  Cole Steber; Joshua Farris; Ryan T Hughes; Corbin A Helis; Tawfeq Naal; Jung W Kim-Shapiro; Travis Jacobson; Michael K Farris
Journal:  Adv Radiat Oncol       Date:  2020-09-22

6.  A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin.

Authors:  Jung Sun Kim; Sang Yup Lim; Jinwook Hwang; Eun Joo Kang; Yoon Ji Choi
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.